Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · IEX Real-Time Price · USD
4.380
-0.030 (-0.68%)
At close: May 3, 2024, 4:00 PM
4.590
+0.210 (4.79%)
After-hours: May 3, 2024, 5:50 PM EDT
Pyxis Oncology Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$9.80
Upside
+123.74%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +59.82% | Apr 10, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | +59.82% | Mar 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $7 | Strong Buy | Maintains | $4 → $7 | +59.82% | Mar 22, 2024 |
| BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +82.65% | Feb 9, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $12 | Buy | Initiates | $12 | +173.97% | Jan 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | -8.68% | Nov 30, 2023 |
| RBC Capital | RBC Capital | Buy Initiates $7 | Buy | Initiates | $7 | +59.82% | Sep 5, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +242.47% | Jul 31, 2023 |
| Credit Suisse | Credit Suisse | Buy Reiterates $14 | Buy | Reiterates | $14 | +219.63% | Mar 23, 2023 |
| B of A Securities | B of A Securities | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 2, 2021 |
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 2, 2021 |
| Credit Suisse | Credit Suisse | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 2, 2021 |